CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations
- Resource Type
- Article
- Source
- In
Journal of Thoracic Oncology April 2024 19(4):613-625 - Subject
- Language
- ISSN
- 1556-0864